The reduction in PSA caused by an increased BMI may lead to men not receiving a biopsy when a smaller man would, which may help explain the observed paradoxical inverse relationship of BMI with prostate cancer detection, but the positive relationship between BMI and increased prostate cancer mortality [24]. The gene discussed is KLK3; the disease is prostate carcinoma.